Startseite Educating health care trainees and professionals about suicide prevention in depressed adolescents
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Educating health care trainees and professionals about suicide prevention in depressed adolescents

  • Timothy R. Rice EMAIL logo und Leo Sher
Veröffentlicht/Copyright: 4. September 2013

Abstract

Adolescent depression is a highly prevalent disorder with significant morbidity and suicide mortality. It is simultaneously highly responsive to treatment. Adolescents wish to discuss depression with their providers, and providers routinely receive opportunities to do so. These characteristics of prevalence, morbidity, mortality, responsiveness, and accessibility make adolescent depression an excellent target of care. However, most health care trainees and professionals report low confidence in caring for adolescent depression. As a caregiver community, we fare poorly in routine matters of assessment and management of adolescent depression. All health care professionals are trained within a medical model. In this light, the conceptualization of adolescent depression and suicidality within the medical model may increase provider confidence and performance. Epidemiology and neurobiology are presented with emphasis in this review. Legal concerns also affect health care professionals. For example, providers may deviate from evidence-based medicine owing to anxieties that the identification and treatment of depression may induce suicide and consequent legal culpability. A review of the historical context and relevant outcome trials concerning the increased risk of suicidality in depressed adolescents treated with selective-serotonin reuptake inhibitors may increase provider comfort. Furthermore, increased didactic and experiential training improve provider performance. In this work, proven models were discussed, and the testable hypothesis that education incorporating the views of this article can produce the best care for depressed adolescents.


Corresponding author: Timothy R. Rice, MD, Department of Psychiatry, Mount Sinai School of Medicine, Box 1230, One Gustave L. Levy Place, New York, NY 10029, USA

References

1. Merikangas KR, He J, Burstein M, Swanson SA, Avenevoli S, et al. Lifetime prevalence of mental disorders in US adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010;49:980–9.10.1016/j.jaac.2010.05.017Suche in Google Scholar PubMed PubMed Central

2. Fleming JE, Boyle MH, Offod DR.The outcome of adolescent depression in the Ontario child health study follow-up. J Am Acad Child Adolesc Psychiatry 1993;32:28–33.10.1097/00004583-199301000-00005Suche in Google Scholar PubMed

3. Weissman MM, Wolk S, Goldstein RB, Moreau D, Adams P, et al. Depressed adolescents grown up. J Am Med Assoc 1999;281:1707–13.10.1001/jama.281.18.1707Suche in Google Scholar PubMed

4. Joffe A, Radius S, Gall M. Health counseling for adolescents: what they want, what they get, and who gives it. Pediatrics 1998;82:481–5.10.1542/peds.82.3.481Suche in Google Scholar

5. Richardson LP, Russo JE, Lozano P, McCauley E, Katon W. Factors associated with detection and receipt of treatment for youth with depression and anxiety disorders. Acad Pediatr 2010;10:36–40.10.1016/j.acap.2009.09.011Suche in Google Scholar PubMed PubMed Central

6. Klein J, Allan M, Elster A, Stevens D, Cox C, et al. Improving adolescent preventive care in community centers. Pediatrics 2001;107:318–27.10.1542/peds.107.2.318Suche in Google Scholar PubMed

7. Fallucco E, Hanson M, Glowinski A. Teaching pediatric residents to assess adolescent suicide risk with a standardized patient module. Pediatrics 2010;125:953–9.10.1542/peds.2009-2135Suche in Google Scholar PubMed

8. Frankenfield D, Keyl P, Gielen A, Wissow L, Werthamer L, et al. Adolescent patients: healthy or hurting? Missed opportunities to screen for suicide risk in the primary care setting. Arch Pediatr Adolesc Med 2000;154:162–8.10.1001/archpedi.154.2.162Suche in Google Scholar PubMed

9. Sudak D, Roy A, Sudak H, Lipschitz A, Maltsberger J, et al. Deficiencies in suicide training in primary care specialties: A survey of training directors. Acad Psychiatry 2007; 22:21–8.10.1176/appi.ap.31.5.345Suche in Google Scholar PubMed

10. Simon RI, Shuman DW. Therapeutic risk management of clinical-legal dilemmas: Should it be a core competency? J Am Acad Psychiatr Law 2009;37:155–61.Suche in Google Scholar

11. Weir JM, Zakama A, Rao U. Developmental risk I: Depression and the developing brain. Child Adoles Psychiatric Clin North Am 2012;21:237–59.10.1016/j.chc.2012.01.004Suche in Google Scholar PubMed PubMed Central

12. Durston S, Hulshoff Pol HE, Casey BJ, Giedd JN, Buitelaar JK, et al. Anatomical MRI of the developing human brain: What have we learned? J Am Acad Child Adolesc Psychiatry 2001;40:1012–20.10.1097/00004583-200109000-00009Suche in Google Scholar

13. Giorgio A, Watkins KE, Chadwick M, James S, Winmill L, et al. Longitudinal changes in grey and white matter during adolescence. Neuro Image 2010;49:94–103.10.1016/j.neuroimage.2009.08.003Suche in Google Scholar

14. McClure HH, Eddy JM, Kjellstrand JM, Snodgrass JJ, Martinez CR Jr. Child and adolescent affective and behavioral distress and elevated adult body mass index. Child Psychiatry Hum Dev 2012 Mar 27. [Online ahead of print].10.1007/s10578-012-0299-9Suche in Google Scholar

15. Mendel JR, Berg CJ, Windle RC, Windle M. Predicting young adulthood smoking among adolescent smokers and nonsmokers. Am J Health Behav 2012;36:542–54.10.5993/AJHB.36.4.11Suche in Google Scholar

16. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 2001;49:1002–14.10.1016/S0006-3223(01)01129-5Suche in Google Scholar

17. Essau CA, Chang WC. Epidemiology, comorbidity, and course of adolescent depression. In: Essau CA, editor. Treatments for adolescent depression: theory and practice. Oxford: Oxford University Press, 2009.Suche in Google Scholar

18. Joinson C, Heron J, Araya R, Paus T, Croudace T, et al. Association between pubertal development and depressive symptoms in girls from a UK cohort. Psychol Med 2012 Apr 12. [Online ahead of print]10.1017/S003329171200061XSuche in Google Scholar PubMed

19. Angold A, Costello EJ. Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. Am J Psychiatry 1993;150:1779–91.10.1176/ajp.150.12.1779Suche in Google Scholar PubMed

20. Costello EJ, Foley DL, Angold A. 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology. J Am Acad Child Adolesc Psychiatry 2006;45:8–25.10.1097/01.chi.0000184929.41423.c0Suche in Google Scholar PubMed

21. Pine DS, Goldstein RB, Wolk S, Weissman MM. The association between childhood depression and adulthood body mass index. Pediatrics 2001;107:1049–56.10.1542/peds.107.5.1049Suche in Google Scholar PubMed

22. Lewinsohn PM, Rohde P, Seeley JR. Adolescent psychopathology: III. The clinical consequences of comorbidity. J Am Acad Child Adolesc Psychiatry 1995;34:510–9.10.1097/00004583-199504000-00018Suche in Google Scholar PubMed

23. Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatr Res 1999;91:127–39.10.1016/S0925-4927(99)00034-7Suche in Google Scholar

24. Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 2009;166:64–73.10.1176/appi.ajp.2008.07081336Suche in Google Scholar PubMed PubMed Central

25. Forbes EE, May JC, Siegle GJ, Ladouceur CD, Ryan ND, et al. Reward-related decision-making in pediatric major depressive disorder: an fMRI study. J Child Psychol Psychiatry 2006;47:1031–40.10.1111/j.1469-7610.2006.01673.xSuche in Google Scholar PubMed PubMed Central

26. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 2010;70:271–88.10.1002/dneu.20774Suche in Google Scholar PubMed PubMed Central

27. Castren E, Rantamki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010;70:289–97.10.1002/dneu.20758Suche in Google Scholar PubMed

28. Sher L. Brain-derived neurotrophic factor and suicidal behavior in adolescents. World J Pediatr 2011;7:197–8.10.1007/s12519-011-0316-2Suche in Google Scholar PubMed

29. Hilt LM, Sander LC, Nolen-Hoeksema S, Simen AA. The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers. Neurosci Lett 2007;429:12–6.10.1016/j.neulet.2007.09.053Suche in Google Scholar PubMed

30. Chen J, Li X, McGue M. Interacting effect of BDNF Val66Met polymorphism and stressful life events on adolescent depression. 2012 Aug 29. [Online ahead of print]10.1111/j.1601-183X.2012.00843.xSuche in Google Scholar PubMed

31. Vigil P, Orellana RF, Cortes ME, Molina CT, Switzer BE, et al. Endocrine modulation of the adolescent brain: A review. J Pediatr Adolesc Gynecol 2011;24:330–7.10.1016/j.jpag.2011.01.061Suche in Google Scholar PubMed

32. Shansky RM, Glavis-Bloom C, Lerman D, McRae P, Benson C, et al. Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry 2004;9:531–8.10.1038/sj.mp.4001435Suche in Google Scholar PubMed

33. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depres- sion meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011;68:444–54.10.1001/archgenpsychiatry.2010.189Suche in Google Scholar

34. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386–9.10.1126/science.1083968Suche in Google Scholar

35. Priess-Groben HA, Hyde JS. 5-HTTLPR X stress in adolescent depression: Moderation by MAOA and gender. J Abnorm Child Psychol 2012 Jul 27. [Online ahead of print]10.1007/s10802-012-9672-1Suche in Google Scholar

36. Lopez-Duran NL, Kovacs M, George CJ. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis. Psychoneuroendocrinology 2009;34:1272–83.10.1016/j.psyneuen.2009.03.016Suche in Google Scholar

37. Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005;20:S302–6.10.1016/S0924-9338(05)80180-4Suche in Google Scholar

38. Mueller A, Brocke B, Fries E, Lesch KP, Kirschbaum C. The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology 2010;35:289–96.10.1016/j.psyneuen.2009.07.002Suche in Google Scholar PubMed

39. Birmaher B, Brent D, Bernet W, Bukstein O, Walkter H, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adoles Psychiatry 2007;46:1503–26.10.1097/chi.0b013e318145ae1cSuche in Google Scholar PubMed

40. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006;132:132–49.10.1037/0033-2909.132.1.132Suche in Google Scholar PubMed PubMed Central

41. Kratochvil CJ, Vitiello B, Walkup J, Emslie G, Waslick BD, et al. Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? J Child Adol Psychol 2006;16:11–24.10.1089/cap.2006.16.11Suche in Google Scholar PubMed

42. Yu Z, Kratochvil CJ, Weller RA, Mooreville M, Weller EB. From TADS and SOFTADS to TORDIA and beyond: What?s new in the treatment of adolescent depression. Curr Psychiatry Rep 2010;12:88–95.10.1007/s11920-010-0094-xSuche in Google Scholar PubMed

43. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, et al. Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205–15.10.1097/00004583-200210000-00010Suche in Google Scholar PubMed

44. Birmaher B, Brent DA, Benson RS. Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998;37:1234–8.10.1097/00004583-199811000-00029Suche in Google Scholar PubMed

45. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: A propensity-adjusted retrospective cohort study. CNS Drugs 2004;18:1119–32.10.2165/00023210-200418150-00006Suche in Google Scholar PubMed

46. Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 2009;48:721–9.10.1097/CHI.0b013e3181a2b304Suche in Google Scholar PubMed

47. March J, Silva S, Petrycki S, Curry J, Wells K, et al. Treatment for Adolescents With Depression (TADS) Team: fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. J Am Med Assoc 2004;292:807–20.10.1001/jama.292.7.807Suche in Google Scholar PubMed

48. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. J Am Med Assoc 2008;299:901–13.10.1001/jama.299.8.901Suche in Google Scholar PubMed PubMed Central

49. The Treatment for Adolescents with Depression (TADS) Team. The Treatment for Adolescents with Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry 2009;166:1141–9.10.1176/appi.ajp.2009.08111620Suche in Google Scholar PubMed

50. Domino ME, Foster EM, Vitiello B, Kratochvil CJ, Burns BJ, et al. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. J Am Acad Child Adolesc Psychiatry 2009;48:711–20.10.1097/CHI.0b013e3181a2b319Suche in Google Scholar PubMed

51. Reinherz H, Tanner J, Berger S, Beardslee W, Fitzmaurice G. Adolescent suicidal ideation as predictive of psychopathology, suicidal behavior, and compromised functioning at age 30. Am J Psychiatry 2006;163:1226–32.10.1176/ajp.2006.163.7.1226Suche in Google Scholar

52. Lindqvist P, Johansson L, Karlsson U. In the aftermath of teenage suicide: a qualitative study of the psychosocial consequences for the surviving family members. BMC Psychiatry 2008;8:26.10.1186/1471-244X-8-26Suche in Google Scholar PubMed PubMed Central

53. Cox GR, Robinson J, Williamson M, Lockley A, Cheung YTD, et al. Suicide clusters in young people: Evidence for the effectiveness of postvention strategies. Crisis 2012;33:2082–14.10.1027/0227-5910/a000144Suche in Google Scholar

54. Centers for Disease Control and Prevention. WISQARS leading causes of death reports, 1999–2009. Atlanta, GA: CDC, 2012.Suche in Google Scholar

55. Patton GC, Coffey C, Sawyer SM, Viner RM, Haller DM, et al. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet 2009;374:881–92.10.1016/S0140-6736(09)60741-8Suche in Google Scholar

56. Macintosh J. USA suicide: 2007 official data: report for the American Association of Suicidology. 2007. Available online at: http://www.suicidology.org/c/document_library/get_file?folderId=228&name=DLFE-494.pdf, access date April 25th, 2012.Suche in Google Scholar

57. Centers for Disease Control and Prevention. Youth risk behavior surveillance – United States, 2009. Morb Mort Week Rep 2010;59(SS-5):1–142.Suche in Google Scholar

58. Hawton K, Saunders KEA, O’Connor RC. Self-harm and suicide in adolescents. Lancet 2012;379:2373–82.10.1016/S0140-6736(12)60322-5Suche in Google Scholar

59. McKeown RE, Cuffe SP, Schulz RM. US suicide rates by age group, 1970–2002: an examination of recent trends. Am J Public Health 2006;96:1744–51.10.2105/AJPH.2005.066951Suche in Google Scholar PubMed PubMed Central

60. Morrell S, Page AN, Taylor RJ. The decline in Australian young male suicide. SocSci Med 2007;64:747–54.10.1016/j.socscimed.2006.09.027Suche in Google Scholar PubMed

61. Kutcher SP, Szumilas M. Youth suicide prevention. Can Med Assoc J 2008;178:282–5.Suche in Google Scholar

62. Varnik A, Kolves K, Allik J, Arensman E, Aromaa E, et al. Gender issues in suicide rates, trends and methods among youths aged 15–24 in 15 European countries. J Affect Disord 2009;113:216–26.10.1016/j.jad.2008.06.004Suche in Google Scholar PubMed

63. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, et al. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164:1356–63.10.1176/appi.ajp.2007.07030454Suche in Google Scholar PubMed

64. Wasserman D, Cheng Q, Jiang GX. Global suicide rates among young people aged 15–19. World Psychiatry 2005;4:114–20.Suche in Google Scholar

65. Hepp U, Stulz N, Unger-Koppel J. Methods of suicide used by children and adolescents. Eur Child Adolesc Psychiatry 2012;21:67–73.10.1007/s00787-011-0232-ySuche in Google Scholar PubMed

66. Skinner R, McFaull S. Suicide among children and adolescents in Canada: trends and sex differences, 1980–2008. Can Med Assoc J 2012;184:1029–34.10.1503/cmaj.111867Suche in Google Scholar PubMed PubMed Central

67. Andrews JA, Lewinsohn PM. Suicidal attempts among older adolescents: prevalence and co-occurrence with psychiatric disorders. J Am Acad Child Adolesc Psychiatry 1992;31: 655–62.10.1097/00004583-199207000-00012Suche in Google Scholar PubMed

68. Hawton K, van Heeringen K. Suicide. Lancet 2009;373:1372–81.10.1016/S0140-6736(09)60372-XSuche in Google Scholar

69. Ganz D, Sher L. Suicidal behavior in adolescents with comorbid depression and alcohol abuse. Minerva Pediatr 2009;61:333–47.Suche in Google Scholar

70. Sher L. The concept of post-traumatic mood disorder. Med Hypotheses 2005;65:205–10.10.1016/j.mehy.2005.03.014Suche in Google Scholar PubMed

71. Sher L. The concept of post-traumatic mood disorder and its implications for adolescent suicidal behavior. Minerva Pediatr 2008;60:1393–9.Suche in Google Scholar

72. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:207–10.10.1176/ajp.147.2.207Suche in Google Scholar PubMed

73. King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, et al. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 1991;30:179–86.10.1097/00004583-199103000-00003Suche in Google Scholar PubMed

74. Beasley CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Br Med J 1991;303:685–92.10.1136/bmj.303.6804.685Suche in Google Scholar PubMed PubMed Central

75. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160:790–2.10.1176/appi.ajp.160.4.790Suche in Google Scholar PubMed

76. Hammad TA. Results of the analysis of suicidality in pediatric trials of newer antidepressants. Psychopharmacology Drugs Advisory Committee and the Pediatric Advisory Committee, September 13–14, 2004. Online document at: www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-review.pdf.Suche in Google Scholar

77. Barry CL, Busch SH. News media coverage of FDA warnings on pediatric antidepressant use and suicidality. Pediatrics 2010;125:88–95.10.1542/peds.2009-0792Suche in Google Scholar PubMed PubMed Central

78. Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry 2009;66:633–9.10.1001/archgenpsychiatry.2009.46Suche in Google Scholar PubMed

79. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884–91.10.1176/ajp.2007.164.6.884Suche in Google Scholar PubMed

80. Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003;60:978–82.10.1001/archpsyc.60.9.978Suche in Google Scholar PubMed

81. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 2006;163:1898–904.10.1176/ajp.2006.163.11.1898Suche in Google Scholar PubMed

82. Gibbons RD, Kwan H, Brown H, Davis JM, Mann JJ. Benefits from antidepressants: synthesis of 6-Week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 2012 Mar 5. [Online ahead of print]10.1001/archgenpsychiatry.2011.2044Suche in Google Scholar PubMed PubMed Central

83. Blazquez A, Mas S, Plana MT, Lafuente A, Lazaro L. Fluoxetine pharmacogenetics in child and adult populations. Eur Child Adolesc Psychiatry 2012 Jul 12. [Online ahead of print]10.1007/s00787-012-0305-6Suche in Google Scholar PubMed

84. Macaluso M, Preskorn SH. How biomarkers will change psychiatry: from clinical trials to practice. Part I: introduction. J Psychiatr Pract 2012;18:118–21.10.1097/01.pra.0000413277.11091.25Suche in Google Scholar PubMed

85. Schmidt HD, Shelton RC, Duman RS. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011;36:2375–94.10.1038/npp.2011.151Suche in Google Scholar PubMed PubMed Central

86. Mann JJ. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 2009;65:556–63.10.1016/j.biopsych.2008.11.021Suche in Google Scholar PubMed PubMed Central

87. Wren FJ, Scholle SH, Heo J, Comer DM. Pediatric mood and anxiety syndromes in primary care: Who gets identified? Int J Psychiatry Med 2003;33:1–16.10.2190/UT6D-RDFG-LBT7-G39NSuche in Google Scholar PubMed

88. Basco MR, Bostic JQ, Davies D, Rush AJ, Witte B, et al. Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry 2000;157:1599–605.10.1176/appi.ajp.157.10.1599Suche in Google Scholar PubMed

89. Stein RE, Horwitz SM, Storfer-Isser A, Heneghan A, Olson L, et al. Do pediatricians think they are responsible for identification and management of child mental health problems? Results of the AAP periodic survey. Ambul Pediatr 2008;8:11–7.10.1016/j.ambp.2007.10.006Suche in Google Scholar PubMed

90. Isometsa E, Heikkinen M, Marttunen M, Henriksson M, Aro H, et al. The last appointment before suicide: Is suicide intent communicated? Am J Psychiatry 1995;152:919–22.10.1176/ajp.152.6.919Suche in Google Scholar PubMed

91. Mckelvey R, Pfaff J, Acres J. The relationship between chief complaints, psychological distress, and suicidal ideation in 15–24-year-old patients presenting to general practitioners. Med J Aust 2001;175:550–2.10.5694/j.1326-5377.2001.tb143718.xSuche in Google Scholar PubMed

92. Gould M, Marrocco F, Kleinman M, Thomas JG, Mostkoff K, et al. Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial. J Am Med Assoc 2005;239:1635.10.1001/jama.293.13.1635Suche in Google Scholar PubMed

93. Cox A, Holbrok D, Rutter M. Psychiatric interviewing techniques, VI: experimental study: eliciting feelings. Br J Psychiatry 1981;139:144–52.10.1192/bjp.139.2.144Suche in Google Scholar PubMed

94. Wissow L, Modena M, Roter D. Pediatrician interview style and mother’s disclosure of psychosocial issues. Pediatrics 1994;93:289.10.1542/peds.93.2.289Suche in Google Scholar

95. Tompson MC, Boger KD, Asarnow JR. Enhancing the developmental appropriateness of treatment for depression in youth: Integrating the family in treatment. Child Adolesc Psychiatr Clin North Am 2012;21:345–84.10.1016/j.chc.2012.01.003Suche in Google Scholar PubMed PubMed Central

96. Diamond GS, Reis BF, Diamond GM, Siqueland L, Issacs L. Attachment-based family therapy for depressed adolescents: a treatment development study. J Am Acad Child Adolesc Psychiatry 2002;41:1190–6.10.1097/00004583-200210000-00008Suche in Google Scholar PubMed

97. Diamond GS, Wintersteen MB, Brown GK, Diamond GM, Gallop R, et al. Attachment-based family therapy for adolescents with suicidal ideation: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2010;49:122–31.Suche in Google Scholar

98. Habis A, Tall L, Smith J, Guenther E. Pediatric emergency medicine physicians’ current practices and beliefs regarding mental health screening. Pediatr Emer Care 2007;23:387–93.10.1097/01.pec.0000278401.37697.79Suche in Google Scholar PubMed

99. Pisani A, Cross W, Gould M. The assessment and management of suicide risk: state of workshop education. Suicide Life Threat Behav 2011;41:255–76.10.1111/j.1943-278X.2011.00026.xSuche in Google Scholar PubMed PubMed Central

100. Rice TR, Sher L. Educating non-mental health care providers about suicide assessment in adolescents. Neuropsychiatry 2012;2:267–70.10.2217/npy.12.33Suche in Google Scholar

Received: 2012-8-15
Accepted: 2012-9-20
Published Online: 2013-09-04
Published in Print: 2013-09-01

©2013 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Editorial
  4. Education of health professionals about adolescent psychiatry
  5. Review Articles
  6. Educating medical professionals about suicide prevention among military veterans
  7. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors
  8. Child sexual abuse and the pathophysiology of suicide in adolescents and adults
  9. Suicidal behavior in Indian adolescents
  10. Use of antidepressants for major depressive disorder in children and adolescents: clinical considerations
  11. Educating health care trainees and professionals about suicide prevention in depressed adolescents
  12. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition
  13. Brain structural and functional changes in adolescents with psychiatric disorders
  14. Dating violence and suicidal behavior in adolescents
  15. Low testosterone levels may be associated with suicidal behavior in older men while high testosterone levels may be related to suicidal behavior in adolescents and young adults: a hypothesis
  16. Military sexual trauma as a determinant in the development of mental and physical illness in male and female veterans
  17. American juvenile justice system: history in the making
  18. The underexamined association between posttraumatic stress disorder, medical illness and suicidal behavior
  19. Prevention of suicidal behavior in adolescents with post-traumatic stress disorder
  20. Bullying, psychiatric pathology and suicidal behavior
  21. Original Articles
  22. Educating medical students about adolescent maltreatment
  23. Cannabis use, addiction risk and functional impairment in youth seeking treatment for primary mood or anxiety concerns
  24. Does the physician density affect suicide rates among adolescents and young adults?
  25. Case Report
  26. Buprenorphine in the treatment of non-suicidal self-injury: a case series and discussion of the literature
Heruntergeladen am 6.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ijamh-2013-0056/html?lang=de
Button zum nach oben scrollen